Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1181-1190 of 2905 for cancer

Edit search filters
  1. A Study Of Taxane, Trastuzumab, And Pertuzumab With Or Without Atezolizumab In Treating Metastatic Breast Cancer Patients

    Eau Claire, WI, La Crosse, WI, Rochester, MN

  2. A Study Of Proton Versus Photon Beam Radiotherapy In The Treatment Of Unilateral Head And Neck Cancer

    Rochester, MN

  3. A Study To Evaluate The Effect Of Diet And Exercise On Biomarkers Associated With Obesity And Breast Cancer In Overweight Women With Early Stage Breast Cancer

    Rochester, MN

  4. Study Of Gastric Cancer And Limited Peritoneal Metastasis Using Robotic Cytoreduction And Hyperthermic Intraperitoneal Chemotherapy

    Rochester, MN

  5. A Study Of MRI-Targeted Biopsy Compared To Standard Ultrasound Guided Biopsy For The Diagnosis Of Prostate Cancer

    Rochester, MN

  6. A Safety Study Of SEA-TGT (SGN-TGT) In Patients With Advanced Cancer

    Rochester, MN

  7. GRAVITAS-301: A Study Of Itacitinib Or Placebo In Combination With Corticosteroids For Treatment Of Acute Graft-Versus-Host Disease

    Rochester, MN

  8. A Study To Evaluate Gemcitabine And MK-3475 (Pembrolizumab) To Treat Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ

  9. A Study To Evaluate A Resilient Living Program For Patients With Advancer Cancer And Their Caregivers

    Rochester, MN

  10. A Study Of Grapiprant And Pembrolizumab In Patients With Advanced Or Progressive MSS Colorectal Cancer

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer